Preoperative Use of Liraglutide Additionally to Common Dietological Measures as Opposed to Dietological Measures Alone
Launched by MEDICAL UNIVERSITY OF VIENNA · Mar 5, 2025
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying the effects of a medication called Saxenda (liraglutide) on weight loss before bariatric surgery in adolescents with obesity. The researchers want to see if taking Saxenda along with a diet plan can help patients lose more weight before their surgery compared to just following the diet alone. There will be two groups in the study: one will receive Saxenda and diet, while the other will only follow the diet.
To be eligible for this trial, participants must be seeking bariatric surgery and have a body mass index (BMI) of over 35. They should be between 18 and 74 years old and must have health insurance from Österreichische Gesundheitskasse. Participants will need to commit to a preoperative diet and attend follow-up appointments for blood tests and weight measurements. It's important to know that people with previous weight loss surgeries, certain health issues, or those unwilling to follow the diet will not be able to join the study. This trial is not yet recruiting, so interested individuals will need to wait for further updates.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • - Patients seeking bariatric surgery
- • BMI \> 35.0 kg/m2
- • Health insurance via Österreichische Gesundheitskasse
- • Willingness to be assigned to either of the two groups
- • Willingness to adhere to preoperative dietological measures
- • Follow-up anticipation with blood draws and body weight scans using Secca scale
- • Written informed consent
- Exclusion Criteria:
- • Patients with previous bariatric surgerys
- • Patients aged below 18 years
- • Patients with BMI \< 35 kg/m2
- • Patients with psychiatric disorders
- • Patients not willing to adhere to preoperative dietological measures
- • Patients with contraindications against Saxenda
- • Patients who have health insurance other than Österreichische Gesundheitskasse
About Medical University Of Vienna
The Medical University of Vienna is a leading research institution dedicated to advancing healthcare through innovative clinical research and education. Renowned for its commitment to excellence in medical science, the university fosters interdisciplinary collaboration among researchers, clinicians, and academic professionals. Its clinical trials encompass a wide range of medical disciplines, aiming to develop cutting-edge therapies and improve patient outcomes. With state-of-the-art facilities and a strong emphasis on ethical standards, the Medical University of Vienna is at the forefront of transforming scientific discoveries into practical applications that enhance global health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported